Releasing agent
Releasing agent (also known as a releaser or releasing factor) is a type of pharmacological agent that induces the release of a neurotransmitter from the neuron into the synapse. This process is essential for the normal functioning of the nervous system and is a key mechanism in the regulation of various physiological processes, including mood, appetite, and sleep.
Mechanism of action[edit | edit source]
Releasing agents function by increasing the amount of neurotransmitter available in the synapse. They do this by binding to and activating the presynaptic neuron's releasing mechanisms, which triggers the release of stored neurotransmitter into the synapse. This increased availability of neurotransmitter can then stimulate the postsynaptic neuron, leading to an amplified signal.
Types of releasing agents[edit | edit source]
There are many different types of releasing agents, each of which targets a specific neurotransmitter system. Some of the most well-known include:
- Dopamine releasing agents (DRAs), which increase the release of dopamine, a neurotransmitter involved in reward and motivation.
- Serotonin releasing agents (SRAs), which increase the release of serotonin, a neurotransmitter involved in mood and appetite regulation.
- Norepinephrine releasing agents (NRAs), which increase the release of norepinephrine, a neurotransmitter involved in alertness and energy.
Clinical uses[edit | edit source]
Releasing agents are used in a variety of clinical settings. For example, certain types of antidepressants and stimulants are releasing agents. These medications can help to alleviate symptoms of conditions such as depression, anxiety, and attention deficit hyperactivity disorder (ADHD) by increasing the availability of certain neurotransmitters in the brain.
Risks and side effects[edit | edit source]
While releasing agents can be beneficial in treating certain conditions, they also carry risks and potential side effects. These can include insomnia, anxiety, nausea, and increased heart rate. In some cases, misuse of these drugs can lead to addiction or neurotoxicity.
See also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
